(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
@ $9.00
Issued: 13 Feb 2024 @ 12:30
Return: 30.00%
Previous signal: Feb 6 - 13:49
Previous signal:
Return: -2.39 %
Live Chart Being Loaded With Signals
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases...
Stats | |
---|---|
Today's Volume | 69 047.00 |
Average Volume | 151 677 |
Market Cap | 476.85M |
EPS | $-0.190 ( 2023-11-09 ) |
Next earnings date | ( $-0.330 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.00 |
ATR14 | $0.0190 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Holles Natalie C. | Buy | 13 558 | Common Stock |
2024-04-11 | Holles Natalie C. | Sell | 13 558 | Common Stock |
2024-04-11 | Holles Natalie C. | Sell | 13 558 | Employee Stock Option (right to buy) |
2024-04-04 | Person Julie | Sell | 1 107 | Employee Option Grant (right to buy) |
2024-04-04 | Person Julie | Buy | 1 107 | Common Stock |
INSIDER POWER |
---|
5.62 |
Last 98 transactions |
Buy: 24 902 019 | Sell: 27 277 881 |
Volume Correlation
Third Harmonic Bio, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Third Harmonic Bio, Inc. Correlation - Currency/Commodity
Third Harmonic Bio, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-35 000.00 (0.00 %) |
EPS: | $-0.780 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-35 000.00 (0.00 %) |
EPS: | $-0.780 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-38 000.00 (0.00 %) |
EPS: | $-0.960 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.730 |
Financial Reports:
No articles found.
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators